DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Niaspan (Niacin Extended-Release) - Drug Interactions, Contraindications, Overdosage, etc




Caution should be used when prescribing niacin (≥1 gm/day) with statins as these drugs can increase risk of myopathy/rhabdomyolysis. Combination therapy with NIASPAN and lovastatin or NIASPAN and simvastatin should not exceed doses of 2000 mg NIASPAN and 40 mg lovastatin or simvastatin daily.. [see Warnings and Precautions and Clinical Pharmacology ] (5)

Bile Acid Sequestrants

An study results suggest that the bile acid-binding resins have high niacin binding capacity. Therefore, 4 to 6 hours, or as great an interval as possible, should elapse between the ingestion of bile acid-binding resins and the administration of NIASPAN. in vitro [see Clinical Pharmacology ]


Concomitant aspirin may decrease the metabolic clearance of nicotinic acid. The clinical relevance of this finding is unclear.

Antihypertensive Therapy

Niacin may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension.


Vitamins or other nutritional supplements containing large doses of niacin or related compounds such as nicotinamide may potentiate the adverse effects of NIASPAN.

Laboratory Test Interactions

Niacin may produce false elevations in some fluorometric determinations of plasma or urinary catecholamines. Niacin may also give false-positive reactions with cupric sulfate solution (Benedict’s reagent) in urine glucose tests.


Supportive measures should be undertaken in the event of an overdose.


NIASPAN is contraindicated in the following conditions:

  • Active liver disease or unexplained persistent elevations in hepatic transaminases [see Warnings and Precautions ]
  • Patients with active peptic ulcer disease
  • Patients with arterial bleeding
  • Hypersensitivity to niacin or any component of this medication [see Adverse Reactions ]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017